Your browser doesn't support javascript.
loading
Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.
Bandiera, Carole; Skrabal Ross, Xiomara; Cardoso, Evelina; Wagner, Dorothea; Csajka, Chantal; Olver, Ian; Patterson, Pandora; Suppiah, Vijayaprakash; Gunn, Kate M; Schneider, Marie.
Affiliation
  • Bandiera C; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel Servet 1, 1211, Geneva, Switzerland. Carole.Bandiera@unisante.ch.
  • Skrabal Ross X; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland. Carole.Bandiera@unisante.ch.
  • Cardoso E; Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland. Carole.Bandiera@unisante.ch.
  • Wagner D; Cancer Research Institute, University of South Australia, Adelaide, Australia.
  • Csajka C; Allied Health and Human Performance, University of South Australia, Adelaide, Australia.
  • Olver I; Canteen Australia, Research, Evaluation and Social Policy Unit, GPO Box 3821, Sydney, New South Wales, 2001, Australia.
  • Patterson P; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Suppiah V; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Gunn KM; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel Servet 1, 1211, Geneva, Switzerland.
  • Schneider M; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Support Care Cancer ; 30(5): 3655-3659, 2022 May.
Article in En | MEDLINE | ID: mdl-34993650
ABSTRACT
Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2)85-96, 2011) and Greer et al. (Oncologist 21(3)354-76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Medication Adherence / Neoplasms Limits: Humans Country/Region as subject: Europa / Oceania Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 2022 Type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Medication Adherence / Neoplasms Limits: Humans Country/Region as subject: Europa / Oceania Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 2022 Type: Article Affiliation country: Switzerland